IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse

Clin Exp Immunol. 2014 May;176(2):199-206. doi: 10.1111/cei.12263.

Abstract

Autoimmune diabetes is characterized by autoantigen-specific T cell-mediated destruction of pancreatic islet beta cells, and CD8(+) T cells are key players during this process. We assessed whether the bitransgenic RIP-CD80 x RIP-LCMV-GP (RIP-CD80GP) mice may be a versatile antigen-specific model of inducible CD8(+) T cell-mediated autoimmune diabetes. Antigen-encoding DNA, peptide-loaded dendritic cells and antigen plus incomplete Freund's adjuvant were used for vaccination. Of 14 pancreatic proteins tested by DNA vaccination, murine pre-proinsulin 2 (100% of mice; median time after vaccination, 60 days) and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) (77%, 58 days) could induce diabetes. Vaccination with DNA encoding for zinc transporter 8, Ia-2, Ia-2β, glutamic acid decarboxylase 67 (Gad67), chromogranin A, insulinoma amyloid polypeptide and homeobox protein Nkx-2.2 induced diabetes development in 25-33% of mice. Vaccination with DNA encoding for Gad65, secretogranin 5, pancreas/duodenum homeobox protein 1 (Pdx1), carboxyl ester lipase, glucagon and control hepatitis B surface antigen (HBsAg) induced diabetes in <20% of mice. Diabetes induction efficiency could be increased by DNA vaccination with a vector encoding a ubiquitin-antigen fusion construct. Diabetic mice had florid T cell islet infiltration. CD8(+) T cell targets of IGRP were identified with a peptide library-based enzyme-linked immunospot assay, and diabetes could also be induced by vaccination with major histocompatibility complex (MHC) class I-restricted IGRP peptides loaded on mature dendritic cells. Vaccination with antigen plus incomplete Freund's adjuvant, which can prevent diabetes in other models, led to rapid diabetes development in the RIP-CD80GP mouse. We conclude that RIP-CD80GP mice are a versatile model of antigen specific autoimmune diabetes and may complement existing mouse models of autoimmune diabetes for evaluating CD8(+) T cell-targeted prevention strategies.

Keywords: antigens/peptides/epitopes; autoimmunity; cytotoxic T cells; diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B7-1 Antigen / genetics
  • B7-1 Antigen / immunology
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism
  • DNA / genetics
  • DNA / immunology
  • Diabetes Mellitus, Type 1 / etiology
  • Diabetes Mellitus, Type 1 / genetics
  • Diabetes Mellitus, Type 1 / immunology*
  • Freund's Adjuvant / immunology
  • Glucose-6-Phosphatase / genetics
  • Glucose-6-Phosphatase / immunology*
  • Glycoproteins / genetics
  • Glycoproteins / immunology
  • Insulin / genetics
  • Insulin / immunology*
  • Islets of Langerhans / immunology
  • Kaplan-Meier Estimate
  • Lipids / immunology
  • Lymphocytic choriomeningitis virus / genetics
  • Lymphocytic choriomeningitis virus / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Promoter Regions, Genetic / genetics
  • Promoter Regions, Genetic / immunology
  • Protein Precursors / genetics
  • Protein Precursors / immunology*
  • Rats
  • Time Factors
  • Vaccination / adverse effects
  • Vaccination / methods*
  • Vaccines, DNA / immunology
  • Viral Proteins / genetics
  • Viral Proteins / immunology

Substances

  • B7-1 Antigen
  • Glycoproteins
  • Insulin
  • Lipids
  • Protein Precursors
  • Vaccines, DNA
  • Viral Proteins
  • incomplete Freund's adjuvant
  • preproinsulin
  • DNA
  • Freund's Adjuvant
  • Glucose-6-Phosphatase
  • G6pc2 protein, mouse